Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 26;18(1):e0280954.
doi: 10.1371/journal.pone.0280954. eCollection 2023.

Scoping review of cytolytic vaginosis literature

Affiliations

Scoping review of cytolytic vaginosis literature

Roni Kraut et al. PLoS One. .

Abstract

Background: Cytolytic vaginosis (CV) is a little-known, controversial condition that is typically not considered for women presenting with vulvovaginitis symptoms. Objective: The objective of this scoping review was to identify and compile the global evidence on CV.

Methods: A medical librarian searched Prospero, Wiley Cochrane Library, Ovid Embase, Ovid Medline, EBSCO CINAHL, ProQuest Dissertations and Theses Global, and Scopus, from inception to April 4, 2019 and updated to October 17, 2021. Studies were eligible if they discussed CV. Two independent reviewers conducted study selection and data extraction.

Results: Sixty-four studies were identified, with 67% of studies (n = 43) published since 2007. Studies were from around the world, including the United States (28%, n = 18), Brazil (11%, n = 7), Portugal (11%, n = 7), and China (11%, n = 7). Fifty percent of studies (n = 32) were reviews; the remainder were observational; and of these, 78% (n = 25) were cross-sectional. The most frequent topics included: diagnosis (19%, n = 12), prevalence (17%, n = 11), and overview of CV (50%, n = 32). Evidence for prevalence in symptomatic women (median prevalence of 5%, interquartile range 3%-8%) was based only on 16% of studies (n = 10) with minimal evidence on prevalence in asymptomatic women and across different geographic regions. Microbiological findings, including abundant lactobacilli and fragmented epithelial cells, were found useful to distinguish between CV and vulvovaginal candidiasis, and Lactobacillus crispatus was noted to dominate the vaginal flora in women with CV. Most studies used subjective criteria to diagnose CV as the condition lacks gold-standard microscopic criteria. The suggested primary treatment (baking soda irrigations) was largely based on expert opinion, and there was minimal evidence on associations between CV and other conditions.

Conclusion: Knowledge gaps currently exist in all realms of CV research. Additional research is needed to confirm the validity of CV and ensure that women are diagnosed and treated effectively.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exit.

Figures

Fig 1
Fig 1. PRISMA flow diagram.
Fig 2
Fig 2. Median prevalence by subgroup.
1.The cut-off of the first group is based on the year of Cibley e’ al.’s study [7] on CV, and the cut-off for the subsequent groups was chosen to divide the remaining years equally between groups.
Fig 3
Fig 3. Wet mounts and gram stains.
A & B, Normal wet mount and gram stain (pleomorphic lactobacilli and superficial cells). C & D, Bacterial vaginosis wet mount and gram stain (lack of lactobacilli, clue cells, and granular flora). E & F, CV wet mount and gram stain (abundant lactobacilli, fragmented epithelial cells: Bare nuclei and cytoplasmic debris). Wet mount magnification: 400x and gram stain magnification 1000x.

Similar articles

Cited by

References

    1. Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18:e339–e347. doi: 10.1016/S1473-3099(18)30103-8 - DOI - PubMed
    1. Menezes CB, Frasson AP, Tasca T. Trichomoniasis—are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide? Microb Cell. 2016;3:404–419. doi: 10.15698/mic2016.09.526 - DOI - PMC - PubMed
    1. Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis. 2019. May;46:304–311. - PubMed
    1. Aballéa S, Guelfucci F, Wagner J, Khemiri A, Dietz JP, Sobel J, et al.. Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidiasis (RVVC) in Europe and the USA. Health Qual Life Outcomes. 2013;11:169. - PMC - PubMed
    1. Bilardi JE, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C, et al.. The burden of bacterial vaginosis: women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLOS ONE. 2013;8:e74378. doi: 10.1371/journal.pone.0074378 - DOI - PMC - PubMed

Publication types